One of today's notable stocks in decline is Endo Pharmaceuticals (NASDAQ:ENDP), down 2.9% to $37.10. The S&P is trading higher by 0.2% to 1,629 and the Dow is trading fractionally higher to 15,059.
Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company with products that provide pain management. The Company researches, develops, produces, and markets both branded and generic pharmaceuticals. Endo's products include Percocet, Percodan, and Lidoderm.
Based on a current price of $37.10, Endo Pharmaceuticals is currently 10.8% above its average consensus analyst price target of $33.08. The stock should discover initial support at its 50-day moving average (MA) of $33.26 and subsequent support at its 200-day MA of $30.44.
Over the past year, Endo Pharmaceuticals has traded in a range of $25.00 to $44.53 and is now at $37.10, 48% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 1.7%.